BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Oasmia 

Vallongatan 1

Uppsala    SE-752 28  Sweden
Phone: 46-18-50-54-40 Fax: 46-18-51-08-73


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Oasmia Wins FDA Conditional Approval For Paccal Vet In Two Canine Cancers 2/28/2014 7:32:37 AM    More...
The Oasmia Annual Report is Now Published 8/22/2013 9:57:22 AM    More...
Oasmia Appoints New Vice President Communications 6/13/2013 8:52:40 AM    More...
Oasmia’s Patented XR-17 Technology Generates Novel Cancer Combination Therapy 5/28/2013 9:05:03 AM    More...
Oasmia Initiates Clinical Program With Paclical® in Metastatic Breast Cancer 5/6/2013 9:18:59 AM    More...
Oasmia and Abbott Animal Health Sign Global Collaboration Agreement for $21.5 Million 1/9/2013 7:21:41 AM    More...
Oasmia and Abbott Laboratories (ABT) Sign Global Collaboration Agreement for Canine Oncology Therapies 1/7/2013 9:44:34 AM    More...
Oasmia Release: Positive Phase III Result From the Interim Analysis of the Study in Ovarian Cancer With Paclical(R) 8/2/2011 10:00:57 AM    More...
Preliminary Analysis Indicates That Oasmia's Product Candidate Paccal(R) Vet Met Primary Endpoint in Phase III Study in Dogs With Mastocytoma 5/4/2010 9:09:26 AM    More...
Abbott Animal Health and Oasmia Announce Exclusive Distribution Agreement for Paccal(r) Vet, a New Chemotherapeutic Agent for Dogs 7/14/2009 8:44:21 AM    More...
12

//-->